Commentary on “PLX-PAD Treatment of Critical Limb Ischaemia: A Clinically Effective Cell Therapy at Long Last?”

European Journal of Vascular and Endovascular Surgery - United Kingdom
doi 10.1016/j.ejvs.2019.02.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Chapter IV: Treatment of Critical Limb Ischaemia

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2011English

Burosumab: At Long Last, an Effective Treatment for FGF23-Associated Hypophosphatemia

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2018English

Cell Therapy for Critical Limb Ischemia: Moving Forward One Step at a Time

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2011English

Limb Salvage in Critical Limb Ischaemia in Thromboangiitis Obliterans Patientsrevascularisation- A Study

Journal of Evolution of Medical and Dental Sciences
2018English

Commentary on “A Prospective Study to Evaluate Complete Wound Healing and Limb Salvage Rates After Angiosome Targeted Infrapopliteal Balloon Angioplasty in Critical Limb Ischaemia Patients”

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2018English

Functional Outcomes Following Revascularisation for Critical Limb Ischaemia

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2012English

Critical Limb Ischaemia Associated With Chemotherapy for Breast Cancer

Journal of the Royal Society of Medicine
Medicine
2004English

Critical Limb Ischaemia in Adult Human Skeletal Muscle Increases Satellite Cell Proliferation but Not Differentiation

Surgical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy